Literature DB >> 35593427

Aspirin prophylaxis for hereditary and acquired thrombotic thrombocytopenic purpura?

Bojing Shao1, Sanober Nusrat2, James N George2,3, Lijun Xia1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35593427      PMCID： PMC9262856          DOI： 10.1002/ajh.26603

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   13.265


× No keyword cloud information.
  6 in total

1.  Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.

Authors:  G A Rock; K H Shumak; N A Buskard; V S Blanchette; J G Kelton; R C Nair; R A Spasoff
Journal:  N Engl J Med       Date:  1991-08-08       Impact factor: 91.245

2.  Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors.

Authors:  Harshvardhan Upreti; Jamil Kasmani; Kathryn Dane; Evan M Braunstein; Michael B Streiff; Satish Shanbhag; Alison R Moliterno; C John Sperati; Rebecca F Gottesman; Robert A Brodsky; Thomas S Kickler; Shruti Chaturvedi
Journal:  Blood       Date:  2019-08-20       Impact factor: 22.113

3.  Prevalence of neuropsychiatric symptoms and stroke in patients with hereditary thrombotic thrombocytopenic purpura.

Authors:  Azra Borogovac; Erika Tarasco; Johanna A Kremer Hovinga; Kenneth D Friedman; Adam S Asch; Sara K Vesely; Calin I Prodan; Deirdra R Terrell; James N George
Journal:  Blood       Date:  2022-08-18       Impact factor: 25.476

4.  Cardiovascular disease is a leading cause of mortality among TTP survivors in clinical remission.

Authors:  Senthil Sukumar; Max Brodsky; Sarah Hussain; Lisa Yanek; Alison Moliterno; Robert Brodsky; Spero R Cataland; Shruti Chaturvedi
Journal:  Blood Adv       Date:  2022-02-22

5.  Morbidities and mortality in patients with hereditary thrombotic thrombocytopenic purpura.

Authors:  Azra Borogovac; Jessica A Reese; Samiksha Gupta; James N George
Journal:  Blood Adv       Date:  2022-02-08

6.  Deletion of platelet CLEC-2 decreases GPIbα-mediated integrin αIIbβ3 activation and decreases thrombosis in TTP.

Authors:  Bojing Shao; Christopher Hoover; Huiping Shi; Yuji Kondo; Robert H Lee; Junmei Chen; Xindi Shan; Jianhua Song; J Michael McDaniel; Meixiang Zhou; Samuel McGee; Karen Vanhoorelbeke; Wolfgang Bergmeier; José A López; James N George; Lijun Xia
Journal:  Blood       Date:  2022-04-21       Impact factor: 22.113
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.